Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.

Viberti G, Wheeldon NM; MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators.

Circulation. 2002 Aug 6;106(6):672-8.

2.

Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

Lewis EJ, Lewis JB.

Clin Exp Nephrol. 2003 Mar;7(1):1-8. Review.

PMID:
14586737
3.

Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.

Frampton JE, Scott LJ.

Am J Cardiovasc Drugs. 2009;9(5):309-30. doi: 10.2165/11201120-000000000-00000. Review.

PMID:
19791840
4.

Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.

Croom KF, Curran MP, Goa KL, Perry CM.

Drugs. 2004;64(9):999-1028. Review.

PMID:
15101793
5.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

6.

Amlodipine/Valsartan: fixed-dose combination in hypertension.

Plosker GL, Robinson DM.

Drugs. 2008;68(3):373-81. Review.

PMID:
18257612
7.

Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.

Galceran J, Plana J, Felip A, Pou G, Vila J, Sobrino J.

Expert Rev Cardiovasc Ther. 2010 Jun;8(6):751-7. doi: 10.1586/erc.10.48. Review.

PMID:
20528630
8.

Renoprotection and renin-angiotensin system blockade in diabetes mellitus.

Ruilope LM.

Am J Hypertens. 1997 Dec;10(12 Pt 2):325S-331S. Review.

PMID:
9438777
10.
11.

Valsartan and the kidney: review of preclinical and clinical data.

Ruilope LM.

Adv Ther. 2001 Mar-Apr;18(2):57-66. Review.

PMID:
11446269
12.

Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.

Volpe M.

Expert Rev Cardiovasc Ther. 2012 Aug;10(8):1061-72. doi: 10.1586/erc.12.80. Review.

PMID:
23030295
13.

Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead.

Kalaitzidis R, Bakris G.

J Clin Hypertens (Greenwich). 2009 Nov;11(11):636-43. doi: 10.1111/j.1751-7176.2009.00184.x. Review.

14.

Microalbuminuria in essential hypertension.

Crippa G.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S74-7. Review.

15.

Treatment of patients with essential hypertension and microalbuminuria.

Redon J.

Drugs. 1997 Dec;54(6):857-66. Review.

PMID:
9421693
16.

Differing effects of antihypertensive agents on urinary albumin excretion.

Weir MR.

Am J Nephrol. 1996;16(3):237-45. Review.

PMID:
8739883
17.

Prognostic significance of albuminuria for the development of nephropathy.

Viberti GF.

J Hypertens Suppl. 1995 Aug;13(2):S87-9. Review.

PMID:
8576795
18.

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.

Mogensen CE.

Diabetologia. 1999 Mar;42(3):263-85. Review. No abstract available.

PMID:
10096778
19.

New trends in the treatment of diabetic nephropathy in children.

Verrotti A, Trotta D, di Corcia G, Chiarelli F.

Expert Opin Pharmacother. 2002 Aug;3(8):1169-76. Review.

PMID:
12150694
20.

Microalbuminuria in essential hypertension.

Mimran A, Ribstein J, Du Cailar G.

Curr Opin Nephrol Hypertens. 1999 May;8(3):359-63. Review.

PMID:
10456269
Items per page

Supplemental Content

Write to the Help Desk